Investor and trader, exclusively in 3D Printing Stocks.
Investing/trading since my teens, I am a strong believer that Additive Manufacturing/3D Printing will grow at a CAGR of 25-30% through the next decade.
Ampio Pharmaceuticals, Inc. is a development stage biopharmaceutical company primarily focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.
Renaissance Capital provides pre-IPO research and global IPO market analytics to institutional investors. The firm manages portfolios of unseasoned equities through the Global IPO Fund (IPOSX), the Renaissance IPO ETF (IPO) and institutional SMAs.
The JXM Database offers a non biased tool that is used to uncover stocks for superior future returns. The database is set up to rank the stocks against each other and the market with the final top ranks representing the best purchase opportunities